The anti-diabetic drug glibenclamide is an agonist of the transient receptor potential Ankyrin 1 (TRPA1) ion channel.

A. Babes,M. Fischer,M. Filipović,M. Engel,M. Flonta,P. Reeh

Published 2013 in European Journal of Pharmacology

ABSTRACT

No abstract is available for this paper.

PUBLICATION RECORD

CITATION MAP

EXTRACTION MAP

CLAIMS

  • No claims are published for this paper.

CONCEPTS

  • No concepts are published for this paper.

REFERENCES

Showing 1-43 of 43 references · Page 1 of 1

CITED BY

Showing 1-44 of 44 citing papers · Page 1 of 1